Tango Therapeutics, Inc. (TNGX)
16.83
+4.48
(+36.28%)
USD |
NASDAQ |
Mar 05, 16:00
17.00
+0.17
(+1.01%)
After-Hours: 20:00
Tango Therapeutics Cash from Investing (Quarterly) : 47.48M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -1.463B |
| Teleflex, Inc. | -22.41M |
| Recursion Pharmaceuticals, Inc. | -1.244M |
| Amicus Therapeutics, Inc. | -6.494M |
| EyePoint Plc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -30.95M |
| Cash from Financing (Quarterly) | 2.541M |
| Free Cash Flow | -146.76M |
| Free Cash Flow Per Share (Quarterly) | -0.2803 |
| Free Cash Flow to Equity (Quarterly) | -30.86M |
| Free Cash Flow to Firm (Quarterly) | -31.10M |
| Free Cash Flow Yield | -7.92% |